Magdalena Huber
- Immunology top 1%
- Immune Cell Function and Interaction 26
- T-cell and B-cell Immunology 22
- Immunotherapy and Immune Responses 11
- Immune cells in cancer 7
- Psoriasis: Treatment and Pathogenesis 5
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 4
- Cancer Research top 5%
- Immunology and Allergy top 10%
- Dermatology top 5%
-
- Research on Leishmaniasis Studies 4
- Co-authors
- Michael LohoffAnne BrüstleHans‐Willi MittrückerAlexander VisekrunaAnna GuralnikTak W. MakSylvia HeinkThomas Kamradt
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- European Journal of Immunology (9 papers)International Immunology (4 papers)Proceedings of the National Academy of Sciences (3 papers)
- Partner nations
- GermanyCanadaSwitzerland
In The Last Decade
Magdalena Huber
60 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Immunology 2.3k
- Oncology 904
- Cancer Research 315
- Immunology and Allergy 87
- Dermatology 119
Countries citing papers authored by Magdalena Huber
This map shows the geographic impact of Magdalena Huber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Huber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Huber more than expected).
Fields of papers citing papers by Magdalena Huber
This network shows the impact of papers produced by Magdalena Huber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Huber. The network helps show where Magdalena Huber may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Magdalena Huber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 11 | |
| 2 | 2024 | 14 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 39 | |
| 10 | 2023 | 8 | |
| 11 | 2023 | 3 | |
| 12 | 2020 | 50 | |
| 13 | 2020 | 5 | |
| 14 | 2017 | 30 | |
| 15 | 2017 | 206 | |
| 16 | 2012 | 190 | |
| 17 | 2011 | 20 | |
| 18 | 2008 | 235 | |
| 19 | The development of inflammatory TH-17 cells requires interferon-regulatory factor 4breakdown → | 2007 | 540 |
| 20 | 1995 | 27 |
About Magdalena Huber
Magdalena Huber is a scholar working on Immunology, Oncology and Cancer Research, having authored 62 papers that have together received 3.3k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (26 papers), T-cell and B-cell Immunology (22 papers), Immunotherapy and Immune Responses (11 papers), Immune cells in cancer (7 papers), Psoriasis: Treatment and Pathogenesis (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Research on Leishmaniasis Studies (4 papers) and CAR-T cell therapy research (4 papers). The work is most often cited by research in Immunology (2.3k citations), Oncology (904 citations) and Cancer Research (315 citations). Magdalena Huber has collaborated with scholars based in Germany, Canada and Switzerland. Frequent co-authors include Michael Lohoff, Anne Brüstle, Hans‐Willi Mittrücker, Alexander Visekruna, Anna Guralnik, Tak W. Mak, Sylvia Heink, Thomas Kamradt, Katharina Reinhard and Enrico Arpaia. Their work appears in journals such as European Journal of Immunology, International Immunology, Proceedings of the National Academy of Sciences, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.